Curran G M, Flynn H A, Kirchner J, Booth B M
HSR&D Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System, 2200 Fort Roots Drive, Building 58, Little Rock, AR 72114, USA.
J Subst Abuse Treat. 2000 Oct;19(3):259-65. doi: 10.1016/s0740-5472(00)00107-0.
We examined the association between relapse-to-drinking and depressive symptomatology measured during inpatient treatment for alcohol disorder and 3 months posttreatment. Data were obtained from 298 veterans who completed 21-day inpatient treatment. Follow-up interviews were conducted at 3, 6, 9, and 12 months posttreatment. We used multiple logistic regression to assess the association between relapse and baseline/3-month posttreatment measures of depression (Beck Depression Inventory; BDI), controlling for important covariates. Our results showed that (a) the mild-to-moderately symptomatic participants (BDI = 14-19) at 3 months posttreatment were on average 2.9 times more likely than the nondepressed to have relapsed across follow-ups, and (b) the severely symptomatic participants (BDI = 20+) at 3 months posttreatment were on average 4.9 times more likely to have relapsed across follow-ups. Other analyses revealed that those with persistent depressive symptomatology reported at both baseline and 3 months posttreatment did not experience worse outcomes that those who reported symptomatology at 3 months posttreatment alone.
我们研究了酒精障碍住院治疗期间及治疗后3个月所测量的复饮与抑郁症状之间的关联。数据来自298名完成21天住院治疗的退伍军人。在治疗后3、6、9和12个月进行随访访谈。我们使用多元逻辑回归来评估复发与抑郁的基线/治疗后3个月测量值(贝克抑郁量表;BDI)之间的关联,并控制重要的协变量。我们的结果表明:(a)治疗后3个月有轻度至中度症状的参与者(BDI = 14 - 19)在随访期间复饮的可能性平均比无抑郁者高2.9倍;(b)治疗后3个月有严重症状的参与者(BDI = 20+)在随访期间复饮的可能性平均高4.9倍。其他分析显示,在基线和治疗后3个月均报告有持续性抑郁症状的参与者,其结局并不比仅在治疗后3个月报告有症状的参与者更差。